| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of SOS2 mRNA | affects expression | 21346803
|
| D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SOS2 mRNA | affects expression | 16483693
|
| D001554 |
Benzene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of SOS2 mRNA | affects cotreatment|increases expression | 17905399
|
| D002117 |
Calcitriol |
Calcitriol results in increased expression of SOS2 mRNA | increases expression | 16002434
|
| C065180 |
fluvastatin |
[zoledronic acid co-treated with fluvastatin] results in increased expression of SOS2 mRNA | affects cotreatment|increases expression | 16996129
|
| C030957 |
methylmercury II |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of SOS2 mRNA | affects cotreatment|increases expression | 17905399
|
| C004648 |
testosterone enanthate |
testosterone enanthate affects the expression of SOS2 mRNA | affects expression | 17440010
|
| D014241 |
Trichloroethylene |
[Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in increased expression of SOS2 mRNA | affects cotreatment|increases expression | 17905399
|
| C088658 |
zoledronic acid |
[zoledronic acid co-treated with fluvastatin] results in increased expression of SOS2 mRNA | affects cotreatment|increases expression | 16996129
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
| MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
4.67 | 19715164 |
| MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
5.77 | 20200999 |
| MESH:D000741 |
Anemia, Aplastic |
|
Benzene |
4.53 | 17661222 11369114 14761424 |
| MESH:D001855 |
Bone Marrow Diseases |
|
Benzene |
5.55 | 16183116 |
| MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
5.18 | 15867366 16121404 17312309 19442620 16778634 11697798 |
| MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.91 | 16769263 8053405 15845617 18496637 18404659 11869084 |
| MESH:D001943 |
Breast Neoplasms |
|
Benzene |
2.14 | 17162533 11921183 |
| MESH:D001943 |
Breast Neoplasms |
|
Calcitriol |
2.14 | 11237771 |
| MESH:D001943 |
Breast Neoplasms |
|
Trichloroethylene |
2.14 | 15986119 |
| MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
2.14 | 16096432 18695136 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
1.78 | 16705839 |
| MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
3.60 | 19233551 |
| MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
3.93 | 18507039 |
| MESH:D002294 |
Carcinoma, Squamous Cell |
|
Calcitriol |
2.67 | 11237771 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
2.90 | 6135515 |
| MESH:D003327 |
Coronary Disease |
|
fluvastatin |
4.93 | 16142594 |
| MESH:D019465 |
Craniofacial Abnormalities |
|
Benzene |
2.45 | 15643154 |
| MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.28 | 18551238 |
| MESH:D003872 |
Dermatitis |
|
Benzene |
5.02 | 15902427 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
4.50 | 18551238 21346803 |
| MESH:D056486 |
Drug-Induced Liver Injury |
|
Trichloroethylene |
4.50 | 7120509 |
| MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Calcitriol |
4.17 | 15138306 |
| MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
6.11 | 16234978 |
| MESH:D006402 |
Hematologic Diseases |
|
Benzene |
4.87 | 16183116 |
| MESH:D019247 |
HIV Wasting Syndrome |
|
testosterone enanthate |
6.06 | 17440010 |
| MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
4.41 | 16769263 |
| MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
5.25 | 18089816 19622757 |
| MESH:D006973 |
Hypertension |
|
Benzene |
3.15 | 17940673 |
| MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
6.51 | 12669777 |
| MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.15 | 16705839 |
| MESH:D007938 |
Leukemia |
|
Benzene |
3.48 | 14694614 18335105 17119257 15935818 |
| MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
4.97 | 18089816 |
| MESH:D007951 |
Leukemia, Myeloid |
|
Benzene |
4.52 | 17506065 |
| MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Benzene |
2.72 | 19478238 |
| MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
2.21 | 7678174 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.82 | 2876784 6135515 2876786 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Benzene |
10.82 | 12562636 |
| MESH:D008114 |
Liver Neoplasms, Experimental |
|
Trichloroethylene |
10.82 | 7955063 |
| MESH:D017563 |
Lung Diseases, Interstitial |
|
Benzene |
5.13 | 14698565 |
| MESH:D008175 |
Lung Neoplasms |
|
Benzene |
2.42 | 12562636 |
| MESH:D008223 |
Lymphoma |
|
Benzene |
3.88 | 17584886 17119257 |
| MESH:D015674 |
Mammary Neoplasms, Animal |
|
Benzene |
4.73 | 12562636 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Benzene |
7.07 | 11921183 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
7.07 | 17312309 |
| MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
3.82 | 16675582 |
| MESH:D009101 |
Multiple Myeloma |
|
Benzene |
13.35 | 17119195 |
| MESH:D009101 |
Multiple Myeloma |
|
fluvastatin |
13.35 | 16996129 |
| MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
13.35 | 16996129 18089719 19621390 |
| MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.15 | 18551238 7678174 |
| MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
3.71 | 19139120 17312309 15867366 |
| MESH:D009369 |
Neoplasms |
|
Trichloroethylene |
3.64 | 11911487 |
| MESH:D009436 |
Neural Tube Defects |
|
Benzene |
3.80 | 15643154 |
| MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
9.82 | 16049721 |
| MESH:D009784 |
Occupational Diseases |
|
Benzene |
9.82 | 15935809 17178637 16737584 17119257 15913788 15576619 15727169 17479406 15612468 |
| MESH:D010014 |
Osteolysis |
|
zoledronic acid |
5.65 | 15867366 |
| MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
4.15 | 17882678 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Benzene |
3.02 | 12562636 |
| MESH:D010146 |
Pain |
|
zoledronic acid |
4.10 | 16475674 |
| MESH:D011470 |
Prostatic Hyperplasia |
|
Calcitriol |
5.06 | 15572423 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Calcitriol |
3.70 | 12479363 16289102 15754350 18247401 16644109 |
| MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
3.70 | 19103299 12438248 |
| MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
5.17 | 16121404 |
| MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.67 | 18551238 |
| MESH:D013274 |
Stomach Neoplasms |
|
Benzene |
2.42 | 12562636 |
| MESH:D013953 |
Thymus Neoplasms |
|
Benzene |
5.24 | 10850423 |
| MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.35 | 16049721 |
| MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.60 | 10091137 |
| MESH:D014594 |
Uterine Neoplasms |
|
Benzene |
4.57 | 12562636 |